MCK Logo

McKesson Corp (MCK) Stock Forecast & Price Prediction

Live MCK Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NYSE | Healthcare | Medical Distribution

$603.40

+7.71 (1.29%)

12 Month Price Forecast For MCK

$603.40
Current Price
$75.29B
Market Cap
17 Ratings
Buy 13
Hold 3
Sell 1
Wall St Analyst Ratings

Distance to MCK Price Forecasts

+20.8%
To High Target of $729.00
+11.9%
To Median Target of $675.00
-11.5%
To Low Target of $534.20

MCK Price Momentum

+0.0%
1 Week Change
+3.7%
1 Month Change
+20.4%
1 Year Change
+5.9%
Year-to-Date Change
-5.4%
From 52W High of $637.51
+29.9%
From 52W Low of $464.42

๐Ÿค” Considering McKesson (MCK)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 11, 2025 10:48 AM UTC

MCK Analyst Ratings & Price Targets

Based on our analysis of 25 Wall Street analysts, MCK has a bullish consensus with a median price target of $675.00 (ranging from $534.20 to $729.00). The overall analyst rating is Strong Buy (8.6/10). Currently trading at $603.40, the median forecast implies a 11.9% upside. This outlook is supported by 13 Buy, 3 Hold, and 1 Sell ratings.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

MCK Analyst Consensus

13
Buy
3
Hold
1
Sell

MCK Price Target Range

Low
$534.20
Average
$675.00
High
$729.00
Current: $603.40

Latest MCK Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for MCK.

Date Firm Analyst Rating Change Price Target
Feb 6, 2025 Evercore ISI Group Elizabeth Anderson Outperform Maintains $675.00
Jan 10, 2025 Citigroup Daniel Grosslight Buy Maintains $677.00
Jan 6, 2025 B of A Securities Michael Cherny Buy Maintains $650.00
Dec 17, 2024 Morgan Stanley Erin Wright Overweight Maintains $642.00
Dec 13, 2024 Wells Fargo Stephen Baxter Equal-Weight Maintains $641.00
Nov 13, 2024 Citigroup Daniel Grosslight Buy Maintains $713.00
Nov 7, 2024 Evercore ISI Group Elizabeth Anderson Outperform Maintains $680.00
Nov 7, 2024 Baird Eric Coldwell Outperform Upgrade $688.00
Oct 7, 2024 Leerink Partners Michael Cherny Outperform Maintains $630.00
Sep 25, 2024 Deutsche Bank George Hill Buy Maintains $579.00
Sep 24, 2024 Baird Eric Coldwell Neutral Downgrade $531.00
Sep 13, 2024 Wells Fargo Stephen Baxter Equal-Weight Maintains $535.00
Sep 10, 2024 Citigroup Daniel Grosslight Buy Maintains $630.00
Sep 5, 2024 Leerink Partners Michael Cherny Outperform Maintains $665.00
Aug 21, 2024 JP Morgan Lisa Gill Overweight Maintains $661.00
Aug 8, 2024 Barclays Steve Valiquette Overweight Maintains $616.00
Aug 8, 2024 Evercore ISI Group Elizabeth Anderson Outperform Maintains $630.00
Aug 8, 2024 Baird Eric Coldwell Outperform Maintains $671.00
Jul 19, 2024 Citigroup Daniel Grosslight Buy Maintains $670.00
Jul 9, 2024 Baird Eric Coldwell Outperform Maintains $694.00

Stocks Similar to McKesson Corp

The following stocks are similar to McKesson based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

McKesson Corp (MCK) Financial Data

McKesson Corp has a market capitalization of $75.29B with a P/E ratio of 27.6x. The company generates $330.19B in trailing twelve-month revenue with a 0.8% profit margin.

Revenue growth is +21.3% quarter-over-quarter, while maintaining an operating margin of +0.8% and return on equity of -187.7%.

Valuation Metrics

Market Cap $75.29B
Enterprise Value $82.16B
P/E Ratio 27.6x
PEG Ratio 16.3x
Price/Sales 0.2x

Growth & Margins

Revenue Growth (YoY) +21.3%
Gross Margin +3.4%
Operating Margin +0.8%
Net Margin +0.8%
EPS Growth -63.7%

Financial Health

Cash/Price Ratio +3.3%
Current Ratio 0.9x
Debt/Equity -2.7x
ROE -187.7%
ROA +3.9%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

McKesson Corp logo

McKesson Corp (MCK) Company Overview

About McKesson Corp

What They Do

Delivers comprehensive healthcare services globally.

Business Model

The company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, Medical-Surgical Solutions, and International. It generates revenue primarily by distributing pharmaceutical products, offering technology and consulting services, and providing logistics and supply chain solutions to healthcare providers and partners.

Additional Information

Founded in 1833 and headquartered in Irving, Texas, McKesson has a long-standing presence in the healthcare industry. Its diverse portfolio allows it to cater to various healthcare needs, making it a crucial player in improving medication access and healthcare delivery.

Company Information

Sector

Healthcare

Industry

Medical Distribution

Employees

45,000

CEO

Mr. Brian S. Tyler Ph.D.

Country

United States

IPO Year

1994

McKesson Corp (MCK) Latest News & Analysis

MCK stock latest news image
Quick Summary

McKesson reported third-quarter revenue below estimates, impacted by weaker-than-expected sales in its U.S. pharmaceutical segment, including branded and specialty drugs.

Why It Matters

McKesson's revenue miss indicates weaker demand in its U.S. pharmaceutical segment, potentially affecting future earnings and investor confidence in the company's growth prospects.

Source: Reuters
Market Sentiment: Negative
MCK stock latest news image
Quick Summary

McKesson (MCK) reported Q3 fiscal 2025 results, exceeding earnings expectations with an adjusted EPS of $8.03, slightly above the forecast of $8.01.

Why It Matters

McKesson's earnings beat indicates strong operational performance, potentially boosting investor confidence and impacting stock performance positively. Mixed results may signal volatility ahead.

Source: The Motley Fool
Market Sentiment: Positive
MCK stock latest news image
Quick Summary

McKesson Corporation (NYSE:MCK) will hold its Q3 2025 earnings conference call on February 5, 2025, at 4:30 PM ET, featuring key executives and analysts from major firms.

Why It Matters

The earnings call will provide insights into McKesson's financial performance and strategy, influencing stock valuation and investor sentiment in the healthcare sector.

Source: Seeking Alpha
Market Sentiment: Neutral
MCK stock latest news image
Quick Summary

McKesson Corporation (NYSE: MCK) released its fiscal 2025 Q3 financial results. A live webcast of the earnings call is scheduled for February 5th at 4:30 PM ET.

Why It Matters

McKesson's Q3 results may impact stock performance and investor sentiment, with key insights expected during the earnings call that could influence future forecasts and market positioning.

Source: Business Wire
Market Sentiment: Neutral
MCK stock latest news image
Quick Summary

McKesson (MCK) reported quarterly earnings of $8.03 per share, slightly below the Zacks estimate of $8.04, but up from $7.74 per share year-over-year.

Why It Matters

McKesson's earnings miss indicates potential challenges in performance despite year-over-year growth, which could impact investor sentiment and stock valuation.

Source: Zacks Investment Research
Market Sentiment: Negative
MCK stock latest news image
Quick Summary

McKesson's Q4 2024 performance shows key metrics against Wall Street estimates and year-ago values, indicating a need for detailed analysis for investors.

Why It Matters

Comparing McKesson's performance metrics to Wall Street estimates and previous year values can reveal growth trends, operational efficiency, and potential stock price movements.

Source: Zacks Investment Research
Market Sentiment: Neutral

Frequently Asked Questions About MCK Stock

What is McKesson Corp's (MCK) stock forecast for 2025?

Based on our analysis of 25 Wall Street analysts, McKesson Corp (MCK) has a median price target of $675.00. The highest price target is $729.00 and the lowest is $534.20.

Is MCK stock a good investment in 2025?

According to current analyst ratings, MCK has 13 Buy ratings, 3 Hold ratings, and 1 Sell ratings. The stock is currently trading at $603.40. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for MCK stock?

Wall Street analysts predict MCK stock could reach $675.00 in the next 12 months. This represents a 11.9% increase from the current price of $603.40. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is McKesson Corp's business model?

The company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, Medical-Surgical Solutions, and International. It generates revenue primarily by distributing pharmaceutical products, offering technology and consulting services, and providing logistics and supply chain solutions to healthcare providers and partners.

What is the highest forecasted price for MCK McKesson Corp?

The highest price target for MCK is $729.00 from at , which represents a 20.8% increase from the current price of $603.40.

What is the lowest forecasted price for MCK McKesson Corp?

The lowest price target for MCK is $534.20 from at , which represents a -11.5% decrease from the current price of $603.40.

What is the overall MCK consensus from analysts for McKesson Corp?

The overall analyst consensus for MCK is bullish. Out of 25 Wall Street analysts, 13 rate it as Buy, 3 as Hold, and 1 as Sell, with a median price target of $675.00.

How accurate are MCK stock price projections?

Stock price projections, including those for McKesson Corp, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.